Giraudo Bryan

CIK 00017408472 companiesNEWARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001740847

Recent Transactions

50 trades

Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2026-05-08$100.00/sh−5,130→ 12,695 total
Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2026-05-08$100.00/sh−6,000→ 0 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2026-05-07$6.98/sh+12,000→ 43,825 total
Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2026-05-07$100.14/sh−36,000→ 27,825 total
Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2026-05-07$100.07/sh−12,000→ 6,000 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2026-05-07−12,000→ 0 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2026-05-07−24,000→ 0 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2026-05-07$6.45/sh+24,000→ 31,825 total
Disposition to Issuer
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2026-03-19−638,000→ 0 total
Disposition to Issuer
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2026-03-19−693,750→ 0 total
Award
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2026-03-19+176,667→ 176,667 total
Award
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2026-03-19+211,500→ 211,500 total
Award
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2026-03-19+211,500→ 211,500 total
Award
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2026-03-19+181,250→ 181,250 total
Award
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2026-03-19+543,750→ 543,750 total
Award
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2026-03-19+638,000→ 638,000 total
Award
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2026-03-19+693,750→ 693,750 total
Disposition to Issuer
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2026-03-19−96,667→ 0 total
Disposition to Issuer
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2026-03-19−47,667→ 0 total
Disposition to Issuer
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2026-03-19−60,000→ 0 total
Disposition to Issuer
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2026-03-19−100,000→ 0 total
Disposition to Issuer
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2026-03-19−176,667→ 0 total
Disposition to Issuer
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2026-03-19−211,500→ 0 total
Disposition to Issuer
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2026-03-19−211,500→ 0 total
Disposition to Issuer
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2026-03-19−181,250→ 0 total
Disposition to Issuer
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2026-03-19−543,750→ 0 total
Award
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2026-03-19+96,667→ 96,667 total
Award
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2026-03-19+47,667→ 47,667 total
Award
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2026-03-19+60,000→ 60,000 total
Award
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2026-03-19+100,000→ 100,000 total
Award
Protagonist Therapeutics, Inc$PTGX
Common Stock
2026-01-02+2,695→ 17,825 total
Award
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2026-01-02+693,750→ 693,750 total
Award
Gossamer Bio, Inc.$GOSS
Common Stock
2026-01-02+115,750→ 389,737 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2026-01-02+3,762→ 3,762 total
Award
Gossamer Bio, Inc.$GOSS
Common Stock
2025-10-01+181,250→ 273,987 total
Award
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2025-03-04+638,000→ 638,000 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2025-01-02+6,584→ 6,584 total
Award
Protagonist Therapeutics, Inc$PTGX
Common Stock
2025-01-02+5,130→ 15,130 total
Purchase
Gossamer Bio, Inc.$GOSS
Common Stock
2024-06-18$0.59/sh+100,000→ 480,010 total
Sale
Gossamer Bio, Inc.$GOSS
Common Stock
2024-03-27$1.16/sh−6,430→ 92,737 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2024-01-02+25,700→ 25,700 total
Award
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2024-01-02+543,750→ 543,750 total
Award
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2023-11-20+181,250→ 181,250 total
Purchase
Gossamer Bio, Inc.$GOSS
Common Stock
2023-11-13$0.56/sh+200,000→ 380,010 total
Award
Gossamer Bio, Inc.$GOSS
Common Stock
2023-07-24$0.13/sh+13,505→ 13,505 total
Award
Gossamer Bio, Inc.$GOSS
Common Stock
2023-07-24$1.82/sh+54,020→ 180,010 total
Disposition to Issuer
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2023-05-05−150,000→ 0 total
Disposition to Issuer
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2023-05-05−90,000→ 0 total
Award
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2023-05-05+60,000→ 60,000 total
Disposition to Issuer
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2023-05-05−71,500→ 0 total

Companies

Recent Filings

Address

C/O PROTAGONIST THERAPEUTICS, INC. 7707 GATEWAY BLVD., SUITE 140

NEWARK, CA, 94560-1160

View on SEC.gov